GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » INIFY Laboratories AB (OSL:INIFY) » Definitions » Common Stock

INIFY Laboratories AB (OSL:INIFY) Common Stock : kr2.99 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is INIFY Laboratories AB Common Stock?

INIFY Laboratories AB's quarterly common stock stayed the same from Jun. 2024 (kr0.00 Mil) to Sep. 2024 (kr0.00 Mil) but then increased from Sep. 2024 (kr0.00 Mil) to Dec. 2024 (kr2.99 Mil).

INIFY Laboratories AB's annual common stock increased from Dec. 2022 (kr2.78 Mil) to Dec. 2023 (kr3.01 Mil) but then declined from Dec. 2023 (kr3.01 Mil) to Dec. 2024 (kr2.99 Mil).


INIFY Laboratories AB Common Stock Historical Data

The historical data trend for INIFY Laboratories AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

INIFY Laboratories AB Common Stock Chart

INIFY Laboratories AB Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Common Stock
0.49 2.78 3.01 2.99

INIFY Laboratories AB Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.01 - - - 2.99

INIFY Laboratories AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


INIFY Laboratories AB Business Description

Traded in Other Exchanges
N/A
Address
Scheeles vag 3, Solna, SWE, 171 65
INIFY Laboratories AB provides cancer diagnostics through ultra-modern laboratory services within pathology. It uses a fully digital, standardized, and AI-supported workflow to optimize quality and response times, initially within the prostate. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer's organization.

INIFY Laboratories AB Headlines

No Headlines